Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 in severe sepsis
NCT02684487Phase 3Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2017
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in sepsis, sponsored by Massachusetts General Hospital. Planned start Dec 2017; status: withdrawn.
02
Drugs
vitamin d
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02684487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02684487.